Moser, Nicola
Sahiti, Floran
Gelbrich, Götz
Cejka, Vladimir
Kerwagen, Fabian
Albert, Judith
Frantz, Stefan
Heuschmann, Peter U.
Störk, Stefan
Morbach, Caroline
Article History
Received: 21 February 2024
Accepted: 14 June 2024
First Online: 14 July 2024
Competing interests
: N.M., F.S., V.C., F.K., J.A., S.F., PU. H.: has no conflicts of interest regarding the present work. G.G.: reports research cooperation with the University Hospital Würzburg and Tomtec Imaging Systems funded by a research grant from the Bavarian Ministry of Economic Affairs, Regional Development and Energy, Germany. S.S.: is supported by the CHFC Würzburg, and by the German Federal Ministry of Education and Research (BMBF). He has received consultancy or lecture fees or reimbursement of travel costs from AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, NovoNordisk, Pharmacosmos, and Servier. C.M.: reports research cooperation with the University of Würzburg and Tomtec Imaging Systems funded by a research grant from the Bavarian Ministry of Economic Affairs, Regional Development and Energy, Germany; advisory and speakers honoraria as well as travel grants from Tomtec, Alnylam, Sobi, Alexion, Janssen, Pfizer, Novo Nordisk, Bayer, and EBR Systems; principal investigator in trials sponsored by Alnylam, AstraZeneca, Novo Nordisk and Bayer.